What technologies does OrganoTherapeutics use?

OrganoTherapeutics uses NSOne, Outlook, Microsoft Office 365, Squarespace ECommerce, Google Font API. View their full technology stack — including all 11 detected tools — on StackWho.

Who is the Co-Founder of OrganoTherapeutics?

Jens Schwamborn is the Co-Founder at OrganoTherapeutics. Get verified contact information on StackWho.

Who is the Co-founder and CSO of OrganoTherapeutics?

Javier Jarazo is the Co-founder and CSO at OrganoTherapeutics. Get verified contact information on StackWho.

Where is OrganoTherapeutics located?

OrganoTherapeutics is based in Esch-sur-Alzette, Luxembourg, Luxembourg.

OrganoTherapeutics

Q: What industry is OrganoTherapeutics in?

OrganoTherapeutics operates in the research industry.

organo-therapeutics.com

research

organo-therapeutics.com

Esch-sur-Alzette, Luxembourg, Luxembourg

1-10 employees

LinkedIn Profile

About OrganoTherapeutics

biotechnology research, neurodegeneration research tools, biotechnology, research and development in the physical, engineering, and life sciences, organoid development, neuroinflammation, organoid automation, regenerative medicine, complex human brain models, medical research, b2b, brain vasculature models, drug discovery, alpha-synuclein aggregation, government, neuroinflammation models, human ipsc-derived models, patient-specific models

OrganoTherapeutics's Tech Stack

AI/ML

Decision Makers at OrganoTherapeutics

2 contacts

Jens Schwamborn

Co-Founder

j***@organo-therapeutics.com Sign up to view

Javier Jarazo

Co-founder and CSO

j***@organo-therapeutics.com Sign up to view

Unlock full contact details including verified emails and LinkedIn profiles

Upgrade to Pro

11 technologies detected · 2 decision makers · Emails available

Sales Outreach Angle

OrganoTherapeutics uses NSOne, Outlook, Microsoft Office 365 among other technologies. Use StackWho to identify the right decision-maker email for targeted sales outreach, recruiting, or partnership development.

OrganoTherapeutics's Position in the StackWho Database

• OrganoTherapeutics is 1 of 7,925 research companies tracked in StackWho.
• 7,883 research companies in our database have verified decision-maker emails (99% of the cohort).
• 878 companies in Luxembourg are in the StackWho database.
• 3,568 research companies are in the 1-10 employee range (same size as OrganoTherapeutics).

Technology detection from public web signals. Decision-maker contacts compiled from LinkedIn public profiles, company filings, and verified outbound testing. Methodology & sources · Updated July 2026.

Frequently Asked Questions

What technology does OrganoTherapeutics use?

OrganoTherapeutics uses NSOne, Outlook, Microsoft Office 365, Squarespace ECommerce, Google Font API, Google Maps, and 5 more technologies. This data is sourced from StackWho's technology detection engine.

How do I contact the decision makers at OrganoTherapeutics?

StackWho has verified email addresses for 2 decision makers at OrganoTherapeutics. Pro members can access direct emails for the CEO, CTO, VP of Engineering, and other key contacts. Use StackWho to reach OrganoTherapeutics directly for sales, recruiting, or partnerships.

What industry is OrganoTherapeutics in?

OrganoTherapeutics operates in the research industry, headquartered in Esch-sur-Alzette, Luxembourg, Luxembourg. StackWho tracks technology stacks and decision maker contacts for companies across all industries.

Can I export OrganoTherapeutics's contact data?

Yes. StackWho Pro members can export decision maker contact data for OrganoTherapeutics and similar companies to CSV. Use the export feature to build targeted prospect lists segmented by technology stack, industry, or location.